| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +0.00% | +46.62% | -1.01% | +47.63% | +47.63% | — |
| 14d | 1 | +0.00% | +10.87% | -1.18% | +12.05% | +12.05% | — |
| 30d | 1 | +100.00% | -5.67% | -1.77% | -3.90% | -3.90% | — |
| 60d | 1 | +100.00% | -45.67% | -5.06% | -40.61% | -40.61% | — |
| 90d | 1 | +100.00% | -60.84% | -9.81% | -51.03% | -51.03% | — |
| 180d | 1 | +100.00% | -89.53% | +4.63% | -94.16% | -94.16% | — |
| 1y | 1 | +100.00% | -74.17% | +13.71% | -87.88% | -87.88% | — |
| 2y | 1(1 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ALT ALTIMMUNE, INC. | PURCHASEGRANT Stock grant | 450,000 | — | — | 450,000 | Oct 1, 2025 | Oct 3, 2025 ↗ | View → |
| ALT ALTIMMUNE, INC. | PURCHASEGRANT Stock grant | 150,000 | — | — | 150,000 | Oct 1, 2025 | Oct 3, 2025 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 850,000 | — | — | 864,207 | Feb 12, 2025 | Feb 14, 2025 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | SALE Chief Medical Officer | 11,624 | $0.45 | $5.3K | 14,207 | Jan 24, 2025 | Jan 27, 2025 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 25,831 | — | — | 25,831 | Jan 23, 2025 | Jan 27, 2025 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 475,831 | — | — | 475,831 | Feb 13, 2024 | Feb 16, 2024 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 180,816 | — | — | 180,816 | Feb 13, 2024 | Feb 28, 2024 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 1,250,000 | $1.28 | $1.60M | 1,250,000 | Aug 31, 2023 | Sep 5, 2023 ↗ | View → |